In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income on investments | 2.2 | 9.4 | 12.8 | 9.9 | 11.5 | 13.6 | 18.0 | 0.3 |
Total interest income | 2.0 | 3.6 | 9.4 | 9.2 | 3.5 | 2.7 | 1.1 | 37.9 |
Total interest expense | 0.4 | 0.6 | 2.6 | 6.6 | 7.0 | 10.0 | 16.9 | 24.3 |
Net interest income | 1.8 | 8.7 | 10.2 | 8.0 | 12.9 | 13.9 | 16.0 | 13.7 |
Net interest income after provision for loan losses | 1.8 | 8.7 | 10.2 | 8.0 | 12.9 | 13.9 | 16.0 | 13.7 |
Gain on sale of investments, net | | | | 0.9 | | | 12.2 | 1.5 |
Other non-interest income | 39.8 | 48.8 | 37.1 | -4.5 | 11.9 | 13.8 | 15.0 | 26.5 |
Total non-interest income | 39.8 | 48.8 | 37.1 | -3.6 | 11.9 | 13.8 | 27.2 | 28.1 |
Equity in earnings | 43.5 | 21.9 | 7.7 | | -8.4 | -21.4 | -26.0 | -26.9 |
Pre-tax income before non-recurring items | 19.0 | 40.5 | 26.1 | -20.1 | 19.9 | -4.6 | -123.2 | 71.8 |
Non-recurring items | 11.9 | | | | | | -23.9 | |
Asset impairment | | | 0.4 | 26.0 | 25.0 | 31.7 | | |
Pre-tax income | 7.1 | 40.5 | 25.7 | -46.1 | -5.1 | -36.3 | -99.4 | 71.8 |
Income taxes | -1.2 | -60.5 | 0.0 | 1.3 | -0.7 | -0.3 | -0.2 | 1.3 |
Tax rate | | | 0.1% | | 13.3% | 0.7% | 0.2% | 1.8% |
Minority interest | | | | -45.3 | -46.6 | -55.0 | -100.4 | -28.0 |
Earnings from continuing ops | 8.4 | 202.0 | 25.6 | 0.6 | 40.8 | 18.4 | 0.8 | 101.1 |
Earnings from discontinued ops | | 0.0 | 35.4 | 18.8 | 1.5 | 0.3 | 18.0 | 26.8 |
Net income | 8.4 | 202.0 | 61.0 | 19.4 | 42.4 | 18.7 | 18.8 | 127.8 |
Net margin | 20.1% | 351.0% | 127.8% | 214.7% | 171.2% | 67.6% | 43.6% | 306.4% |
|
Basic EPS | $1.44 | $34.37 | $4.46 | $0.09 | $6.53 | $2.67 | $0.10 | $12.00 |
Diluted EPS | $1.44 | $34.37 | $4.25 | $0.09 | $6.16 | $2.67 | $0.10 | $11.59 |
|
Shares outstanding (basic) | 5.8 | 5.9 | 5.8 | 5.9 | 6.3 | 6.9 | 7.6 | 8.4 |
Shares outstanding (diluted) | 5.8 | 5.9 | 6.0 | 5.9 | 6.6 | 6.9 | 7.6 | 8.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |